Centers for Disease Control and Prevention, China
62
3
5
39
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
1.6%
1 terminated/withdrawn out of 62 trials
97.5%
+11.0% vs industry average
34%
21 trials in Phase 3/4
10%
4 of 39 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (62)
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
Role: collaborator
Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccine Uptake Among Healthcare Workers in China
Role: lead
Child Vaccination Scheduling in China
Role: collaborator
Pneumoconiosis and Dust Exposure China Cohort
Role: collaborator
Rural China Electric Kettle Promotion Program
Role: collaborator
Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine
Role: collaborator
POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China
Role: collaborator
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
Role: collaborator
Chinese Heart Healthy Diet for People With High Cardiovascular Risk in China (DECIDE-Diet)
Role: collaborator
Real World App-based CCAAP Management of Children With Asthma
Role: collaborator
Methadone Maintenance and HIV Prevention: A Window of Opportunity in China
Role: collaborator
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years
Role: collaborator
Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean
Role: collaborator
Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)
Role: collaborator
Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 1)
Role: collaborator
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23
Role: lead
Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults
Role: collaborator
Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention
Role: collaborator
A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China
Role: lead
Immunogenicity of Hepatitis B Vaccination Among Drug Users
Role: collaborator